Related Experiment Video
Updated: Jan 10, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
AI-Assisted Cardiovascular Risk Assessment by General Practitioners in Resource-Constrained Indonesian Settings Using
Anindya Pradipta Susanto1,2,3, David Lyell1, Bambang Widyantoro4
1Centre for Health Informatics, Australian Institute of Health Innovation, Macquarie University, 75 Talavera Road, Sydney, 2113, Australia, 61 423309268.
Artificial intelligence (AI) clinical decision support (CDS) significantly improves atherosclerotic cardiovascular disease (ASCVD) risk assessment and statin prescription in resource-constrained settings. AI-CDS also reduces physician decision-making time, enhancing efficiency in primary care.
Area of Science:
- Digital health and Artificial Intelligence (AI)
- Cardiovascular disease prevention
- Health informatics
Background:
- Preventive strategies integrating digital health and AI show promise for mitigating atherosclerotic cardiovascular disease (ASCVD).
- AI-enabled clinical decision support (CDS) offers patient-specific insights beyond traditional risk factors.
- The efficacy of AI-CDS in resource-constrained settings for ASCVD risk management is under-explored.
Purpose of the Study:
- To evaluate the impact of AI-based CDS on 10-year ASCVD risk assessment and management in primary prevention.
- To compare AI-based CDS with automated CDS and no decision support in a primary care context.
Main Methods:
- A 3-way, within-subject randomized controlled study involving 102 doctors in Indonesia.
- Doctors assessed 10-year ASCVD risk and management decisions for 9 clinical vignettes under three conditions: AI-based CDS, automated CDS, or no support.
- Outcomes included correct risk assessment, patient management (aspirin, statin, antihypertensive prescriptions, referrals), decision-making time, and perceived AI utility.
Main Results:
- AI-based CDS improved ASCVD risk assessment by 27% and statin prescription by 29% compared to no support.
- AI-assisted decision-making was significantly more accurate for risk assessment and statin prescription, with a number needed to treat of 3.7 for correct risk classification.
- AI-assisted cases required less decision-making time (63.6s vs 72.8s), while improvements in aspirin/antihypertensive prescriptions and referral decisions were not statistically significant.
Conclusions:
- AI-based CDS demonstrates significant potential for improving ASCVD risk assessment and statin prescribing in resource-constrained primary care settings.
- Reduced decision-making time with AI-CDS highlights its value for efficient healthcare resource utilization.
- Further research is warranted to confirm the real-world applicability of these findings in low-resource environments.
More Related Videos
Related Concept Videos
Pre-Procedural Guidelines for Assessing Blood Pressure
Coronary Artery Disease IV: Preventive Measures
Assessment of blood pressure in brachial artery(two-step method)
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Assessment of apical radial pulse
The A-R pulse assessment involves simultaneous evaluation of the apical and radial pulses. When the apical and radial pulse rates vary, this assessment helps identify a pulse deficit.
Pre-Procedural Preparation

